Is sclerostin a reliable biomarker for disease severity? Evaluation of sclerostin levels in the serum and gingival crevicular fluid of rheumatoid arthritis patients with periodontitis: A case‒controlled study | ||
| Ain Shams Dental Journal | ||
| Volume 38, Issue 2, June 2025, Pages 549-558 PDF (1.1 M) | ||
| Document Type: Original articles | ||
| DOI: 10.21608/asdj.2025.341604.1703 | ||
| Authors | ||
| Aya Ali Hussien1; Omina B.Attia2; Ebtehal Mohammed* 3; Mahetab Abdal Wahab4 | ||
| 1oral medicine and periodontology- Faculty of Dentistry- Egyptian Russian University- Cairo- Egypt | ||
| 2Internal Medicine Department, Rheumatology Division, Faculty of Medicine, Ain Shams University, Cairo, Egypt | ||
| 3Oral medicine and Periodontology, Faculty of Dentistry, Beni-Suef University. | ||
| 41. Oral Medicine ,Periodontology And Oral Diagnosis Faculty Of Dentistry .Ain Shams University. 2. Department of Oral Medicine, Periodontology and Oral Diagnosis, Faculty of Dentistry- Egyptian Russian University- Cairo- Egypt | ||
| Abstract | ||
| Aim: In the present study, we selected Rheumatoid arthritis (RA) with stage III periodontitis as both diseases are characterized by bone loss to evaluate the reliability of sclerostin, as a biomarker for disease severity, in both the serum and gingival crevicular fluid (GCF). Materials and methods: A total of 36 participants were included in this study, with 12 participants in each group: patients with RA with stage III periodontitis, healthy patients with stage III periodontitis and healthy controls. Serum samples and GCF samples were collected from the pocket with greatest clinical attachment loss in periodontitis patients and the gingival sulcus of healthy controls. The sclerostin concentration in the samples was assessed by enzyme-linked immune assay (ELIZA). Results: There was no significant difference between the serum or GCF sclerostin levels of the three groups. Additionally, there was no association between the serum and GCF sclerostin levels among or within the groups. Conclusion: Among the limitations of the present study, sclerostin did not reflect the severity of periodontitis or RA. However, it may reflect the disease activity with further studies are recommended. | ||
| Keywords | ||
| Sclerostin; disease biomarker; periodontitis; rheumatoid arthritis | ||
|
Statistics Article View: 5 PDF Download: 3 |
||
